m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT05061
|
[1] | |||
Non-coding RNA
miR-615-3p
YTHDF2
lncRNA miRNA circRNA
Direct
Enhancement
m6A modification
FBLN1
FBLN1
YTHDF2
: m6A sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | YTH domain-containing family protein 2 (YTHDF2) | READER | |||
| m6A Target | Fibulin-1 (FBLN1) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | Non-coding RNA (ncRNA) | ||||
| Epigenetic Regulator | hsa-miR-615-3p | microRNA | View Details | ||
| Regulated Target | YTH domain-containing family protein 2 (YTHDF2) | View Details | |||
| Crosstalk Relationship | ncRNA → m6A | Enhancement | |||
| Crosstalk Mechanism | ncRNAs directly impacts m6A modification through recruiting m6A regulator | ||||
| Crosstalk Summary | hsa-miR-615-3p inhibited Fibulin-1 (FBLN1) and osteogenic differentiation of umbilical cord mesenchymal stem cells by associated with YTHDF2 in a m6A-miRNA interaction manner | ||||
| Responsed Disease | Maxillofacial bone defect is a critical obstacle for maxillofacial tumors and periodontal diseases. | ICD-11: NA02 | |||
In-vitro Model |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
: m6A sites